Masimo Reports Q4 2024 Financial Results and 2025 Guidance

Story Highlights
Masimo Reports Q4 2024 Financial Results and 2025 Guidance

Masimo ( (MASI) ) has issued an update.

On February 25, 2025, Masimo announced its financial results for the fourth quarter and full-year 2024, reporting a 9% increase in consolidated revenue for the quarter. The company also provided updated guidance for 2025, highlighting strategic realignment efforts expected to boost earnings and cash flow. The healthcare segment showed strong growth, while the non-healthcare segment experienced a decline. The company plans to classify its Sound United business as ‘held for sale’ and focus on its core healthcare operations.

More about Masimo

Masimo operates in the healthcare industry, specializing in innovative medical technologies. The company focuses on providing solutions for patient care, with a strong emphasis on addressing unmet clinical needs.

YTD Price Performance: 1.28%

Average Trading Volume: 471,774

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $9.14B

For a thorough assessment of MASI stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App